Population Pharmacokinetics of Caspofungin among Extracorporeal Membrane Oxygenation Patients during the Postoperative Period of Lung Transplantation

Qianlin Wang,Zhu Zhang,Donglin Liu,Wenqian Chen,Gang Cui,Pengmei Li,Xianglin Zhang,Min Li,Qingyuan Zhan,Chen Wang
DOI: https://doi.org/10.1128/aac.00687-20
IF: 5.938
2020-10-20
Antimicrobial Agents and Chemotherapy
Abstract:Little is known about the influence of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics (PK) of caspofungin. The aim of this study was to describe population PK of caspofungin in patients with and without ECMO during the postoperative period of lung transplantation (LTx) and to investigate covariates influencing caspofungin PK. We compared ECMO patients with non-ECMO patients, and patients before and after ECMO weaning as self-controls, to analyzed changes in caspofungin PK. Eight serial blood samples were collected from each patient for PK analysis.
pharmacology & pharmacy,microbiology
What problem does this paper attempt to address?